Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2003
11/20/2003US20030216401 Anti-obesity 1, 2, 3, 4, 10, 10a-hexahydropyrazino[1, 2-a] indoles
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216393 Administering to a patient in need an effective pain treating amount of a substituted 1-aminobutan-3-ol compound to treat migraines, hyperalgesia, inflammatory pain, and post-operative pain
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030216388 Cyclocarbamate derivatives as progesterone receptor modulators
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030216368 Hormone replacement therapy
11/20/2003US20030216362 Estra-1,3,5 (10)-triene derivatives
11/20/2003US20030216356 Cause the selective destruction of tumour vasculature; are used to inhibit and/or reverse, and/or alleviate symptoms of angiogenesis
11/20/2003US20030216335 Treating endometriosis by contacting the subject with a nucleic acid that modulates the expression of VEGF, VEGFR1, and/or VEGFR2
11/20/2003US20030216328 Androgen derivatives and uses thereof
11/20/2003US20030216307 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215496 Solid carrier includes a hydrophililc surfactant and a drug
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003US20030215443 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/20/2003CA2485389A1 Formulations useful in the treatment of male and female impotence
11/20/2003CA2485264A1 Formulations useful in the treatment of male and female impotence
11/20/2003CA2485167A1 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003CA2480488A1 Novel diazabicyclic biaryl derivatives
11/20/2003CA2480378A1 Novel azacyclic ethynyl derivatives
11/19/2003EP1362858A1 Pyrrolopyrimidinone derivates, process of preparation and use
11/19/2003EP1362592A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kB
11/19/2003EP1362588A1 Medicinal compositions comprising diclofenac and ornoprostil
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362034A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
11/19/2003EP1362031A1 Pharmaceutically active piperidine derivatives
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
11/19/2003EP1361882A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/19/2003EP1361876A2 Novel cannabimimetic ligands
11/19/2003EP1361869A2 Transdermal therapeutic system containing testosterone and method for the production thereof
11/19/2003EP1240141B1 New modulators of dopamine neurotransmission
11/19/2003EP1214076B1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
11/19/2003EP1196153B1 Process for the improvement of spermatozoa fertilization activity
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP0857173B1 Meiosis regulating compounds
11/19/2003CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
11/19/2003CN1456548A Process for extracting leonuridine from fresh motherwort and leonuridine preparation
11/19/2003CN1456325A Transcription against leukoplakia and production of its products
11/19/2003CN1456303A Xiaorupi tablets against hyperplasia of mammary glands and preparation thereof
11/19/2003CN1456302A Rupikang tablets against hyperplasia of mammary glands and preparation thereof
11/19/2003CN1456301A Acadthopanax tablets for climacteric and preapration thereof
11/19/2003CN1456298A Sugarless kidney composite medicines and preparation thereof
11/19/2003CN1456297A Tablet for regulating menstruation and removing spot, preparing method thereof
11/19/2003CN1456295A Wuji Baifen pian and preparing method thereof
11/19/2003CN1456289A Preparing method gynaecologic capsule for regulating menstruation
11/19/2003CN1456288A Preparation of Rupishu tablets against hyperplasia of mammary glands
11/19/2003CN1456267A Preparation of tablets against irregular manstruation
11/19/2003CN1456263A Fresh motherwort juice-oral liquid preparing method
11/19/2003CN1456257A Fresh motherwort particle preparing method
11/19/2003CN1456255A Preparation of inducing yang capsules
11/19/2003CN1456253A Fresh motherwort tablet preparing method
11/19/2003CN1456251A Fresh motherwort pulp preparing method
11/19/2003CN1456246A Preparation of tablets against dysmenorrhea
11/19/2003CN1456245A Preparation of tablets for profuse menstruation
11/19/2003CN1456244A Preparation of capsules against cervitis
11/19/2003CN1456240A Preparation of mastotic cystic hyperplasia eliminating capsules
11/19/2003CN1456237A Preparation of instant woman medicine
11/19/2003CN1456236A Preparation of woman effervescent tablets
11/19/2003CN1456206A Qi-blood tonifying capsule
11/19/2003CN1456198A Angong hemostatics
11/19/2003CN1456175A Pelma musk contraceptive paste and preparing method thereof
11/19/2003CN1456155A Mesilate phentolamine suppository and its preparation
11/19/2003CN1127965C Chinese medicine preparation for hyperlasia of mammary glands
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649627 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea
11/18/2003US6649620 Quinoline and quinazoline compounds useful in therapy
11/18/2003US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants
11/18/2003US6649145 Wound healing, treating infections
11/13/2003WO2003093456A1 Soya cell strains with high isoflavone content
11/13/2003WO2003093292A1 17α-FLUOROALKYL-11β-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS
11/13/2003WO2003093272A1 Imidazo-triazine derivatives as ligands for gaba receptors
11/13/2003WO2003093267A1 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
11/13/2003WO2003093245A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003WO2003093234A1 Melanocortin receptor ligands
11/13/2003WO2003092699A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003WO2003092690A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003092653A1 Apparatus and method for delivery of bacteria to the vaginal tract
11/13/2003WO2003092652A1 Warming and nonirritating anhydrous lubricant compositions
11/13/2003WO2003092651A1 Warming and nonirritating lubricant compositions
11/13/2003WO2003092605A2 Protease inhibitors
11/13/2003WO2003092588A2 4-azasteroid derivatives as androgen receptor modulators
11/13/2003WO2003092580A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003WO2003072090A3 Use of tyrosine kinase inhibitors for treating cns disorders
11/13/2003WO2003066621A8 Piperidine derivatives and their use as antagonists of tachykinins
11/13/2003WO2003066001A3 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
11/13/2003WO2003031407A3 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003013432A3 Methods of use for novel sulfur containing organic nitrate compounds
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002014348B1 Glycoproteins and methods of use thereof
1 ... 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 ... 557